Panel views "healthy donuts" via nano-tech

23 February 2009

European food companies already use nano-technology in consumer products, but few volunteer the information to consumers, said Dutch  food scientist Frans Kampers. He was among the panelists gathered in  Chicago for the American Association for the Advancement of Science  annual meeting symposium "From Donuts to Drugs: Nano-Biotechnology  Evolution or Revolution." Dr Kampers from Wageningen University and  Research Center in the Netherlands took a look at food science issues in  his presentation, "What Nanotechnology Can Do for Your Average Donut."

"On the food side there is greater public resistance to nano-materials  and nanotechnology in food whereas on the biomedical side there is  greater public acceptance or less recalcitrance," said Rod Hill, a  University of Idaho professor and symposium organizer.

His focus on applications, products and processes, and on sensors useful  for in food safety and food quality monitoring and in packaging,  reflects the wide range of nano-technology's use in the food industry,  Dr Kampers said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight